Benedetta Fontanella
University of Brescia
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Benedetta Fontanella.
European Journal of Heart Failure | 2008
Marco Metra; Savina Nodari; Giovanni Parrinello; T. Bordonali; Silvia Bugatti; Rossella Danesi; Benedetta Fontanella; Carlo Lombardi; Patrizia Milani; Giulia Verzura; G. Cotter; Howard C. Dittrich; Barry M. Massie; Livio Dei Cas
Renal function is a powerful prognostic variable in patients with heart failure (HF). Hospitalisations for acute HF (AHF) may be associated with further worsening of renal function (WRF).
Cases Journal | 2009
Giorgio Caretta; Debora Robba; Ivano Bonadei; Melissa Teli; Benedetta Fontanella; Enrico Vizzardi; Davide Farina; Riccardo Raddino; Livio Dei Cas
Paradoxical embolism is defined as a systemic arterial embolism requiring the passage of a venous thrombus into the arterial circulatory system through a right-to-left shunt. It is a relatively rare phenomenon, representing about 2% of all cases of arterial embolism. We report a case of a 79-years-old woman admitted to hospital because of dyspnea and lower left limb pain. CT scan revealed multiple thrombi to kidney, lower limb and superior mesenteric artery during acute pulmonary embolism. Echocardiogram documented a patent foramen ovale with a right-to-left shunt. The patient was treated with thrombolytic therapy and heparin with progressive improvement of symptoms and resolution of pulmonary embolism and peripheral thrombosis. Patent foramen ovale closure was not performed because a life-long anticoagulation therapy was necessary, a tunnel-type patent foramen ovale may increases difficulty in realizing device implantation and there are no clear evidence-based guidelines to date addressing treatment in presence of a patent foramen ovale.
Heart International | 2007
Marco Metra; Savina Nodari; T. Bordonali; Silvia Bugatti; Benedetta Fontanella; Carlo Lombardi; Alberto Saporetti; Giulia Verzura; Rossella Danesi; Livio Dei Cas
Anemia is one of the most frequent co-morbidities in the patients with heart failure. Its prevalence increases from 4–7% in the subjects with asymptomatic left ventricular dysfunction to >30% in the patients with severe heart failure. Renal insufficiency, activation of inflammatory mediators, and treatment with renin-angiotensin antagonists seem to be its main determinants. The results of many studies agree in showing that anemia is a powerful independent determinant of survival in patients with heart failure. However, the mechanisms of this relation are still incompletely understood. Moreover a favourable effect on prognosis of the correction of anemia has not been shown, yet, and also controlled studies assessing its effects on exercise tolerance have yielded controversial results.
Therapeutics and Clinical Risk Management | 2007
Marco Metra; Savina Nodari; T. Bordonali; Patrizia Milani; Carlo Lombardi; Silvia Bugatti; Benedetta Fontanella; Giulia Verzura; Rossella Danesi; Livio Dei Cas
Kardiologia Polska | 2010
Benedetta Fontanella; Enrico Vizzardi; T. Bordonali; Antonio D’Aloia; Ermanna Chiari; Livio Dei Cas
Archive | 2010
Benedetta Fontanella; Enrico Vizzardi; T. Bordonali; Antonio D'Aloia; Ermanna Chiari; Livio Dei Cas
Giornale italiano di cardiologia | 2010
Benedetta Fontanella; Metra M; Raffaele Giubbini; T. Bordonali; C. Lombardi; Clara Villa; Marianna Adamo; Rossella Danesi; L. Dei Cas
European Journal of Heart Failure Supplements | 2008
Silvia Bugatti; Metra M; S. Nodari; T. Bordonali; Benedetta Fontanella; C. Lombardi; Patrizia Milani; Giulia Verzura; V. Zaca; L. Dei Cas
European Journal of Heart Failure Supplements | 2008
T. Bordonali; Metra M; S. Nodari; Luca Bettari; Silvia Bugatti; Benedetta Fontanella; C. Lombardi; Patrizia Milani; Giulia Verzura; L. Dei Cas
European Journal of Heart Failure Supplements | 2008
Giulia Verzura; Metra M; S. Nodari; T. Bordonali; Silvia Bugatti; Rossella Danesi; Benedetta Fontanella; C. Lombardi; V. Zaca; L. Dei Cas